UGT1A1genotype and irinotecan therapy: general review and implementation in routine practice-Reference-Cited by-同舟云学术

UGT1A1genotype and irinotecan therapy: general review and implementation in routine practice

Published:2015-05-04 Issue:3 Volume:29 Page:219-237
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Etienne-Grimaldi Marie-Christine¹,Boyer Jean-Christophe²,Thomas Fabienne³,Quaranta Sylvie⁴,Picard Nicolas⁵,Loriot Marie-Anne⁶,Narjoz Céline⁶,Poncet Delphine⁷,Gagnieu Marie-Claude⁸,Ged Cécile⁹,Broly Franck¹⁰,Le Morvan Valérie¹¹,Bouquié Régis¹²,Gaub Marie-Pierre¹³,Philibert Laurent¹⁴,Ghiringhelli François¹⁵,Le Guellec Chantal¹⁶,

Affiliation:

1. Laboratoire d'Oncopharmacologie; EA 3836; Centre Antoine Lacassagne; 33 Av de Valombrose 06189 Nice Cedex 2 France

2. Unité de Toxicologie; Laboratoire de Biochimie; CHU Carémeau, Place du Pr Debré; 30029 Nîmes Cedex France

3. Institut Claudius Regaud; 1, avenue Irène Joliot-Curie 31059 Toulouse France

4. Service de Pharmacocinétique et Toxicologie; Laboratoire de Biologie Médicale; Hôpital de la Timone; Bât F; 264 rue Saint Pierre 13385 Marseille Cedex 05 France

5. Service Pharmacologie; Toxicologie et Pharmacovigilance; CHU Limoges, Bâtiment CBRS; 2 avenue Martin Luther King 87042 Limoges France

6. Hôpital Européen Georges Pompidou; SERVICE BIOCHIMIE; 20 Rue Leblanc 75015 Paris France

7. Equipe Signalisation Métabolisme et Progression Tumorale; UMR 1052-5286; Centre Léon Bérard; 28 rue Laennec 69373 Lyon Cedex 08 69008 Lyon France

8. Fédération de Biochimie; UF Pharmacologie Spécialisée; Hôpital E. Herriot; 5 place d'Arsonval 69437 Lyon Cedex 03 France

9. Plateau Technique de Biologie Moléculaire; Pôle de Biologie et Pathologie; CHU de Bordeaux; 1, place A Raba Leon 33 000 Bordeaux France

10. Service de Toxicologie et Génopathies; Centre de Biologie Pathologie Génétique; Centre Hospitalier Régional et Universitaire de Lille; 59037 Lille Cedex France

11. Institut Bergonié; Unité Inserm VINCO; 229 cours de l'Argonne 33076 Bordeaux Cedex France

12. Laboratoire de Pharmacologie clinique; Institut de Biologie - CHU Nantes; 9, quai Moncousu 44093 Nantes Cedex 1 France

13. EA3430; FMTS Université de Strasbourg; Laboratoire de Biochimie- Biologie Moléculaire; Hôpital de hautepierre; Avenue Molière 67098 Strasbourg France

14. Unité de Biopathologie et pharmacogénétique; Laboratoire d'oncopharmacologie; Institut régional du Cancer Montpellier - Val d'Aurelle; 208 Avenue des Apothicaires 34298 Montpellier Cedex 5 France

15. Département de biopathologie; Centre Georges Francois Leclerc; 1 rue du professeur Marion 21000 Dijon France

16. Unité de pharmacogénétique; Laboratoire de biochimie et biologie moléculaire; CHU Bretonneau; 2 bis boulevard Tonnellé 37044 Tours France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12117/fullpdf

Reference81 articles.

1. CPT-11 (irinotecan) in the treatment of colorectal cancer;Armand;Eur. J. Cancer,1995

2. The current status of irinotecan (CPT-11) in the United States;Rothenberg;Ann. N. Y. Acad. Sci.,1996

3. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer;Fuchs;J. Clin. Oncol.,2003

4. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study;Benard-Laribiere;Fundam. Clin. Pharmacol.,2015

5. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2;Humerickhouse;Cancer Res.,2000

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

2. Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study;Investigational New Drugs;2024-07-22

3. Population-scale variability of the human UDP-glycosyltransferase gene family;Journal of Genetics and Genomics;2024-07

4. UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?;Critical Reviews in Oncology/Hematology;2024-04

5. The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2023-12-22